Amgen Inc.
AMGN
$269.78
$0.400.15%
| Weiss Ratings | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Fair | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.45 | |||
| Price History | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.01% | |||
| 30-Day Total Return | -0.80% | |||
| 60-Day Total Return | -14.39% | |||
| 90-Day Total Return | -2.22% | |||
| Year to Date Total Return | -9.49% | |||
| 1-Year Total Return | 13.24% | |||
| 2-Year Total Return | 8.33% | |||
| 3-Year Total Return | 5.97% | |||
| 5-Year Total Return | 56.45% | |||
| 52-Week High % Change | -18.30% | |||
| 52-Week Low % Change | 27.24% | |||
| Price | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $329.72 | |||
| 52-Week Low Price | $211.71 | |||
| 52-Week Low Price (Date) | Jun 01, 2023 | |||
| 52-Week High Price (Date) | Feb 05, 2024 | |||
| Valuation | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 144.25B | |||
| Enterprise Value | 198.73B | |||
| Price/Earnings (TTM) | 21.52 | |||
| Earnings Per Share (TTM) | 12.49 | |||
| Earnings Per Share Growth | 3.23% | |||
| Price/Earnings To Growth | 6.70 | |||
| Price/Sales (TTM) | 5.15 | |||
| Price/Book (Q) | 23.10 | |||
| Enterprise Value/Revenue (TTM) | 7.06 | |||
| Price | $269.38 | |||
| Enterprise Value/EBITDA (TTM) | 16.28 | |||
| Enterprise Value/EBIT | 24.42 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 540.00M | |||
| Dividend Yield | 3.21% | |||
| Div. Per Share (Most Recent) | $2.25 | |||
| Dividend Per Share (TTM) | $8.64 | |||
| Payout Ratio (TTM) | 67.83% | |||
| Dividend Per Share (Most Recent) | $2.25 | |||
| Company Info | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 805 447 1000 | |||
| Address | One Amgen Center Drive Thousand Oaks, CA 91320-1799 | |||
| Website | www.amgen.com | |||
| Country | United States | |||
| Year Founded | 1980 | |||
| Profitability | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 28.90% | |||
| Profit Margin | 23.82% | |||
| Management Effectiveness | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 6.28% | |||
| Return on Equity | 135.79% | |||
| Income Statement | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 26.91B | |||
| Total Revenue (TTM) | 28.19B | |||
| Revenue Per Share | $52.20 | |||
| Gross Profit (TTM) | 19.74B | |||
| EBITDA (TTM) | 12.22B | |||
| EBIT (TTM) | 8.15B | |||
| Net Income (TTM) | 6.72B | |||
| Net Income Avl. to Common (TTM) | 6.72B | |||
| Total Revenue Growth (Q YOY) | 19.84% | |||
| Earnings Growth (Q YOY) | -52.54% | |||
| EPS Diluted (TTM) | 12.49 | |||
| EPS Diluted Growth (Q YOY) | -52.42% | |||
| Balance Sheet | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 10.94B | |||
| Cash Per Share (Q) | $20.27 | |||
| Total Current Assets (Q) | 30.33B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 6.23B | |||
| Current Ratio (Q) | 1.649 | |||
| Book Value Per Share (Q) | $11.64 | |||
| Total Assets (Q) | 97.15B | |||
| Total Current Liabilities (Q) | 18.39B | |||
| Total Debt (Q) | 65.42B | |||
| Total Liabilities (Q) | 90.92B | |||
| Total Common Equity (Q) | 6.23B | |||
| Cash Flow | AMGN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -26.20B | |||
| Cash from Financing (TTM) | 21.05B | |||
| Net Change in Cash (TTM) | 3.32B | |||
| Levered Free Cash Flow (TTM) | 3.11B | |||
| Cash from Operations (TTM) | 8.47B | |||
